Cargando…
Diffuse myocardial fibrosis - a therapeutic target? Proof of regression at 1-year following aortic valve replacement: the RELIEF-AS study
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032105/ http://dx.doi.org/10.1186/1532-429X-18-S1-O37 |
| _version_ | 1782454927119876096 |
|---|---|
| author | Treibel, Thomas A Fontana, Marianna Kozor, Rebecca Reant, Patricia Espinosa, Maria A Castelletti, Silvia Bulluck, Heerajnarain Bhuva, Anish N White, Steven K Herrey, Anna S Manisty, Charlotte Moon, James C |
| author_facet | Treibel, Thomas A Fontana, Marianna Kozor, Rebecca Reant, Patricia Espinosa, Maria A Castelletti, Silvia Bulluck, Heerajnarain Bhuva, Anish N White, Steven K Herrey, Anna S Manisty, Charlotte Moon, James C |
| author_sort | Treibel, Thomas A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5032105 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50321052016-09-29 Diffuse myocardial fibrosis - a therapeutic target? Proof of regression at 1-year following aortic valve replacement: the RELIEF-AS study Treibel, Thomas A Fontana, Marianna Kozor, Rebecca Reant, Patricia Espinosa, Maria A Castelletti, Silvia Bulluck, Heerajnarain Bhuva, Anish N White, Steven K Herrey, Anna S Manisty, Charlotte Moon, James C J Cardiovasc Magn Reson Oral Presentation BioMed Central 2016-01-27 /pmc/articles/PMC5032105/ http://dx.doi.org/10.1186/1532-429X-18-S1-O37 Text en © Treibel et al. 2016 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Treibel, Thomas A Fontana, Marianna Kozor, Rebecca Reant, Patricia Espinosa, Maria A Castelletti, Silvia Bulluck, Heerajnarain Bhuva, Anish N White, Steven K Herrey, Anna S Manisty, Charlotte Moon, James C Diffuse myocardial fibrosis - a therapeutic target? Proof of regression at 1-year following aortic valve replacement: the RELIEF-AS study |
| title | Diffuse myocardial fibrosis - a therapeutic target? Proof of regression at 1-year following aortic valve replacement: the RELIEF-AS study |
| title_full | Diffuse myocardial fibrosis - a therapeutic target? Proof of regression at 1-year following aortic valve replacement: the RELIEF-AS study |
| title_fullStr | Diffuse myocardial fibrosis - a therapeutic target? Proof of regression at 1-year following aortic valve replacement: the RELIEF-AS study |
| title_full_unstemmed | Diffuse myocardial fibrosis - a therapeutic target? Proof of regression at 1-year following aortic valve replacement: the RELIEF-AS study |
| title_short | Diffuse myocardial fibrosis - a therapeutic target? Proof of regression at 1-year following aortic valve replacement: the RELIEF-AS study |
| title_sort | diffuse myocardial fibrosis - a therapeutic target? proof of regression at 1-year following aortic valve replacement: the relief-as study |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032105/ http://dx.doi.org/10.1186/1532-429X-18-S1-O37 |
| work_keys_str_mv | AT treibelthomasa diffusemyocardialfibrosisatherapeutictargetproofofregressionat1yearfollowingaorticvalvereplacementthereliefasstudy AT fontanamarianna diffusemyocardialfibrosisatherapeutictargetproofofregressionat1yearfollowingaorticvalvereplacementthereliefasstudy AT kozorrebecca diffusemyocardialfibrosisatherapeutictargetproofofregressionat1yearfollowingaorticvalvereplacementthereliefasstudy AT reantpatricia diffusemyocardialfibrosisatherapeutictargetproofofregressionat1yearfollowingaorticvalvereplacementthereliefasstudy AT espinosamariaa diffusemyocardialfibrosisatherapeutictargetproofofregressionat1yearfollowingaorticvalvereplacementthereliefasstudy AT castellettisilvia diffusemyocardialfibrosisatherapeutictargetproofofregressionat1yearfollowingaorticvalvereplacementthereliefasstudy AT bulluckheerajnarain diffusemyocardialfibrosisatherapeutictargetproofofregressionat1yearfollowingaorticvalvereplacementthereliefasstudy AT bhuvaanishn diffusemyocardialfibrosisatherapeutictargetproofofregressionat1yearfollowingaorticvalvereplacementthereliefasstudy AT whitestevenk diffusemyocardialfibrosisatherapeutictargetproofofregressionat1yearfollowingaorticvalvereplacementthereliefasstudy AT herreyannas diffusemyocardialfibrosisatherapeutictargetproofofregressionat1yearfollowingaorticvalvereplacementthereliefasstudy AT manistycharlotte diffusemyocardialfibrosisatherapeutictargetproofofregressionat1yearfollowingaorticvalvereplacementthereliefasstudy AT moonjamesc diffusemyocardialfibrosisatherapeutictargetproofofregressionat1yearfollowingaorticvalvereplacementthereliefasstudy |